Cargando…
Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
Autores principales: | Schäfer, C, Dietl, B, Kölbl, O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361266/ https://www.ncbi.nlm.nih.gov/pubmed/16705316 http://dx.doi.org/10.1038/sj.bjc.6603076 |
Ejemplares similares
-
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
por: Soo, K-C, et al.
Publicado: (2005) -
Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
por: Kumpitsch, Christina, et al.
Publicado: (2020) -
Rabbit VX2 head and neck squamous cell models for translational head and neck theranostic technology development
por: Muhanna, Nidal, et al.
Publicado: (2021) -
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023) -
No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
por: Ameziane, Najim, et al.
Publicado: (2009)